Abstract
The hypothesis of the feasibility of one-point in vivo calibration of intravenously implanted glucose sensors during periods of rapid rise and decline of venous blood glucose concentration was tested. Miniature (5 × 10-4 cm2 mass transporting area) glucose electrodes with 10−90% response times r2, was 0.949 ± 0.020, and the percent difference through the 2−22 mM range was 1.9 ± 1.0%. The results suggest that, in combination with understanding and modeling of transient physiological differences between the subcutaneous and the blood glucose concentrations, it will be possible to calibrate by one-point in vivo calibration subcutaneously implanted sensors, even while the glucose concentration changes rapidly.